Our website uses cookies so that we can provide you a better online experience and service;
by continuing, you agree to our use of cookies in line with our Privacy Statement
Open submenu
11 May 2016 - 11:00

DuPont Nutrition & Health Launches New Prenatal and Postnatal Probiotic Demonstrated to Support the Development of Long-lasting Immune Health Benefits in Infants

DuPont Nutrition & Health is launching a new, clinically tested probiotic, HOWARU® Protect EarlyLife, as part of its premium ingredient range.  EarlyLife contains the probiotic strain Lactobacillus rhamnosus HN001TM and has been formulated specifically for expectant mothers and their infants.

The launch of HOWARU® Protect EarlyLife is backed by a ground-breaking, long-term trial which demonstrated a significant protective effect against eczema during the first six years of an infant’s life.  The study also demonstrated a protective effect on allergic sensitization at six years of age.  

‘We are extremely encouraged by the strong results given from this ongoing long-term trial for HOWARU® Earlylife. The study shows a decrease in the cumulative prevalence of eczema by 49% in children at 2 years of age,’ said Markus Lehtinen, r&d manager. ‘And importantly the effect on this group persisted up to 6 years of age, indicating a long term benefit for children.’

DuPont has a history of delivering innovative solutions by applying its in-depth knowledge of probiotic science and the health ingredients market, and HOWARU® Protect EarlyLife is no exception.  This new probiotic formulation has demonstrated exceptionally encouraging trial results and is introducing it to the market this year. Earlylife will be available as a shelf-ready dietary supplement in a convenient stick-pack format or alternatively, customers can use DuPont applications expertise when they include this unique ingredient in their own products.

‘As the prevalence of eczema and allergies has risen worldwide, there is a growth in demand for safe dietary supplements which support the developing immune system of infants, hence the importance of HOWARU® EarlyLife’, said Ole Danielsen, global marketing director, dietary supplements. ‘In addition, the robust shelf-life of our probiotics means that EarlyLife can be added to existing products, opening up many exciting opportunities for our customers to create their own winning food and beverage formulations.’

Focus on Health
DuPont Nutrition & Health has a detailed understanding of how probiotics may improve cardiovascular, digestive and immune health. HOWARU® Premium Probiotics are friendly cultures that are condition-specific with highly documented health-enhancing benefits. FloraFIT® Custom Probiotics offer the widest selection of strains in the industry, giving infinite possibilities for creating one-of-a-kind formulations.


DuPont Nutrition & Health combines in-depth knowledge of food and nutrition with current research and expert science to deliver unmatched value to the food, beverage and dietary supplement industries. We are innovative solvers, drawing on deep consumer insights and a broad product portfolio to help our customers turn challenges into high-value business opportunities. Follow us on LinkedIn.

DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802.  The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment.  For additional information about DuPont and its commitment to inclusive innovation, please visit www.dupont.com.

This is business-to-business information intended for food and supplement producers, journalists, and healthcare providers and is not intended for the final consumer. To the best of our knowledge this information is based on reliable research and development work. However, DuPont does not assume any liability or risk involved in the use of its products, as conditions of use are beyond our control. Manufacturers should check local regulatory status of any claims according to the intended use of their product.

Richard Donovan
Richard Donovan
Communications Manager
+33 (0) 6 71 58 98 54
Paris, France